HCA Healthcare Inc (NYSE: HCA) has reported E.P.S. of $5.53 for its second fiscal quarter (ending June 30) versus $4.35 for the same period a year ago — an increase of 27%. Relative to the consensus estimate of $4.91, this was a premium of $0.62. For the latest four quarters through June 30, E.P.S. were $21.47 compared to $20.66 a year ago — an increase of 4%.
Recent Price Action
HCA Healthcare Inc (NYSE: HCA) stock closed at $340.17 on 7/23/24 after a large increase of 4.5%. Moreover, trading volume in this advance was exceptionally high at 223% of normal. The stock has risen 7.3% during the last week and has been exceptionally strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to fall short of the cost of capital, HCA is expected to be an important Value Eraser.
HCA Healthcare is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment